Concepedia

Helen Bidner

HB

Statistics

Publications

3

Citations

113

H-Index

3

Active since

2019

Affiliations

German Center for Neurodegenerative Diseases(Current)

Technical University of Munich

Universität Ulm

University of Miami

Leipzig University

Helen Bidner is an author at German Center for Neurodegenerative Diseases specializing in neuropathology, neurology, and neurodegenerative diseases.

Top concepts

Publications per year

2019–2024

3

Publications

3

ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis

Paul Lingor, Markus Weber, William Camu et al. · Frontiers in Neurology · 2019 · 75 citations · Full text

Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial

Jan Christoph Koch, Andreas Leha, Helen Bidner et al. · The Lancet Neurology · 2024 · 21 citations · Full text

, , +6

Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson’s disease (ROCK-PD)

Andreas Wolff, Helen Bidner, Yvonne Remane et al. · Frontiers in Aging Neuroscience · 2024 · 17 citations · Full text

1–3 of 3